Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan Xue

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Breast Cancer Research and Treatment|July 13, 2007
Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese womenLori C Sakoda, Christie R Blackston, Kan Xue, et al.
BMJ Open|August 13, 2018
Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trialZiyu Li, Fei Shan, Xiangji Ying, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 27, 2018
[Comparison of the safety and the costs between laparoscopic assisted or totally laparoscopic uncut Roux-en-Y and BillrothII(+Braun reconstruction--a single center prospective cohort study]Yinkui Wang, Ziyu Li, Fei Shan, et al.
Cancer Letters|January 3, 2016
Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trialsFei Shan, Rulin Miao, Kan Xue, et al.
Oncotarget|August 4, 2016
ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patientsZiyu Li, Xiaofang Xing, Fei Shan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2025
Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forestsJiyao Xing, Yinkui Wang, Min Cao, et al.
Frontiers in Oncology|January 9, 2023
The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancerJun-Bing Chen, Zi-Ning Liu, Yin-Kui Wang, et al.
Expert Review of Medical Devices|May 29, 2025
Four-step formula for the Siewert classification of adenocarcinomas of the esophagogastric junction: a computed tomography-based quantitative modelYi-Ting Liu, Yong-Ai Li, Jia-Zheng Li, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Breast Cancer Research and Treatment|July 13, 2007
Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese womenLori C Sakoda, Christie R Blackston, Kan Xue, et al.
BMJ Open|August 13, 2018
Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trialZiyu Li, Fei Shan, Xiangji Ying, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|March 27, 2018
[Comparison of the safety and the costs between laparoscopic assisted or totally laparoscopic uncut Roux-en-Y and BillrothII(+Braun reconstruction--a single center prospective cohort study]Yinkui Wang, Ziyu Li, Fei Shan, et al.
Cancer Letters|January 3, 2016
Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trialsFei Shan, Rulin Miao, Kan Xue, et al.
Oncotarget|August 4, 2016
ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patientsZiyu Li, Xiaofang Xing, Fei Shan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2025
Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forestsJiyao Xing, Yinkui Wang, Min Cao, et al.
Frontiers in Oncology|January 9, 2023
The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancerJun-Bing Chen, Zi-Ning Liu, Yin-Kui Wang, et al.
Expert Review of Medical Devices|May 29, 2025
Four-step formula for the Siewert classification of adenocarcinomas of the esophagogastric junction: a computed tomography-based quantitative modelYi-Ting Liu, Yong-Ai Li, Jia-Zheng Li, et al.
Pageof 3